3495 Hacks Cross Road, Memphis, TN 38125

Tel (901) 526-7444 Fax (901) 526-0791

Toll Free: (888) 2GI-PATH
Richard S Kinsey, M.D., Laboratory Director
CLIA # 44D0915029

Accession Number: PAN-22-040622

Patient: Williams, Tiara
Address: 1053 Cullenwood Rd Office Visit Date: 11/4/2022 1:11PM
Memphis, TN 38116 Specimen Received: 11/4/2022
Gender: F DOB: 11/29/1988 Age: 33 MR/Chart: 26717626/
Physician: Jackie Makapugay, MD Referring
Client: PHC DRIVE THRU TESTING Physician:

SOURCE OF SPECIMEN: NASAL SWAB

CLINICAL HISTORY: Cough; Shortness of breath; Exposure to COVID-19 Patient; Fever,
unspecified; Chills, without fever; Myalgia Unspecified Site; Headache; Sore Throat (acute); Fatigue;
Nasal Congestion
SARS-CoV-2 RESULT:

Pathogen Name Result

COVID-19 (SARS-CoV-2) POSITIVE
The Aptima SARS-CoV-2 assay is a nucleic acid amplification test (e.g., RT-PCR or TMA) intended for the qualitative detection of RNA
from SARS-CoV-2 isolated and purified from nasopharyngeal (NP), nasal and oropharyngeal (OP) swab specimens collected in viral
transport medium (VTM/UTM), saline, Liquid Amies, or specimen transport medium (STM) from individuals meeting CDC COVID-19
clinical criteria (e.g., clinical signs and symptoms associated with SARS-Cov-2 infection) in conjunction with CDC COVID-19
epidemiological criteria (e.g., history of residence in or travel to a geographic region with active SARS-CoV-2 transmission at the time of
travel, or other epidemiologic criteria for which SARS-CoV-2 testing may be indicated.

This test was developed by Hologic on PantherTM System and its performance characteristics verified by Poplar Healthcare. PantherTM
Aptima SARS-CoV-2 test is FDA approved under Emergency Use Authorization (EUA). Poplar Healthcare is regulated under CLIA as
qualified to perform high-complexity testing.

The performance of this test was established based on the evaluation of a limited number of clinical specimens. Clinical performance has
not been established with all circulating variants but is anticipated to be reflective of the prevalent variants in circulation at the time and
location of the clinical evaluation. Performance at the time of testing may vary depending on the variants circulating, including newly
emerging strains of SARS-CoV-2 and their prevalence, which change over time.

FDA EUA-approved Fact Sheet for Covid testing for patients and healthcare providers are available at https://www.phc-covid.com/

Anami Patel, Ph.D. MB (ASCP) CM DLM CM

Chief Science Officer
Electronically signed Nov 4, 2022
Date Reported: Nov 4, 2022

CPT Code: U0003

ICD Code: